<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/alembic-pharma-fda-approval-generic-ciprodex-otic-suspension</loc>
    <lastmod>2026-10-17T22:36:23+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-17T00:00:00+05:30</news:publication_date>
      <news:title>Alembic Pharma Gains FDA Approval for Generic Ciprodex Otic Suspension in U.S. Market</news:title>
      <news:keywords>Alembic</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/71231680-c20d-4ea7-a2d6-1f1b8711353c/a83fb056-ac2b-44dd-81b0-9f659ee70494.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/viatris-fda-approval-ryzumvi-presbyopia-phentolamine-ophthalmic</loc>
    <lastmod>2026-10-17T22:35:28+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-17T00:00:00+05:30</news:publication_date>
      <news:title>Viatris Gains FDA Approval for RYZUMVI in Presbyopia, Expanding Phentolamine Ophthalmic Indications</news:title>
      <news:keywords>Viatris</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://newsroom.viatris.com/file.php/181193/Refreshed_Viatris_Logo_thumb.png?thumbnail=144</image:loc>
    </image:image>
  </url>
</urlset>